Riskpilot← Back to searchSign inGet full accessVitamind Oy
OYActiveY-tunnus 2597952-6Aallonkatu 2-B10Other human health activities n.e.c. · NACE 8699Est. 2014— employeeswww.vitamind.fi
Revenue 2025
EUR 1,3M
+8% vs 2024
EBITDA margin
5.2%
-46% vs 2024
Equity ratio
49.4%
Financial strength
Net profit 2025
EUR 41K
-54% vs 2024
| Revenue | EUR 1,3M | +8% |
| EBITDA | EUR 69K | -46% |
| Net profit | EUR 41K | -54% |
| Total assets | EUR 342K | +23% |
| Equity | EUR 169K | -10% |
| Employees | — | — |
Legal name
Vitamind Oy
Y-tunnus number
2597952-6
Legal form
Osakeyhtiö
NACE code
8699 · Other human health activities n.e.c.
Founded
18. tammikuuta 2014
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen jäsenet ja toimitusjohtaja kukin yksin
Company purpose
Psykologin tutkimukset ja konsultaatiot, neuropsykologiset tutkimukset, neuropsykologinen kuntoutus, psykoterapia, työterveyspsykologin palvelut, tietojen antaminen, neuvonta ja ohjanta, työnohjaus, koulutus.
Address
Aallonkatu 2-B10
Phone
+3580503310452
Email
tatu.kauranen@vitamind.fi
Website
www.vitamind.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 830 | 886 | 1 085 | 1 243 | 1 344 |
| Staff expenses | −206 | −194 | −148 | −152 | −169 |
| EBITDA | 49 | 25 | 123 | 129 | 69 |
| Depreciation & amort. | −12 | −11 | −14 | −16 | −17 |
| EBIT | 37 | 14 | 108 | 113 | 53 |
| Net financials | −1 | −1 | −1 | −1 | −1 |
| Profit before tax | 36 | 12 | 108 | 112 | 52 |
| Tax | 7 | 3 | 22 | 22 | 11 |
| Net profit | 29 | 10 | 86 | 90 | 41 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 212 | 206 | 235 | 277 | 342 |
| Equity | 133 | 132 | 158 | 188 | 169 |
| Long-term debt | 15 | 11 | 6 | 2 | 0 |
| Short-term debt | 64 | 63 | 71 | 88 | 173 |
| Total debt | 79 | 74 | 77 | 89 | 173 |
EBITDA margin
5.2%
This company
15.8%
Market median
-67% vs market
20212025
Equity ratio
49.4%
This company
38.2%
Market median
+29% vs market
20212025
Return on equity
24.3%
This company
18.4%
Market median
+32% vs market
20212025
Net profit margin
3.1%
This company
8.1%
Market median
-62% vs market
20212025
Asset turnover
3.93×
This company
1.12×
Market median
+251% vs market
20212025
Debt / equity
1.02×
This company
0.62×
Market median
-65% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
TV Chief Executive Officer | Chief Executive Officer | 2021 |
PA Deputy Member | Deputy Member | 2025 |
| Former (1) | ||
JP Audit | Audit | 2021 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Vitamind Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tatu Valtteri Kauranen | Chief Executive Officer | 0 companies |
| Petja Ano Elia Kauranen | Deputy Member | 0 companies |
| Juha Petteri Väärälä | Audit | 0 companies |
| Viveka Kukka Karoliina Kauranen | Board of Directors | 0 companies |